Alnylam Pharmaceuticals, Inc. (ALNY) vs Moderna, Inc. (MRNA)

Alnylam Pharmaceuticals, Inc. and Moderna, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $78.8B against $31.2B — 2.5× the size. Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; Alnylam Pharmaceuticals, Inc. trades at 43.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against −27.6%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs −141.4%) and the higher return on invested capital (0.00% vs −93.5%). Across the 18 metrics below, Alnylam Pharmaceuticals, Inc. leads on 16 and Moderna, Inc. on 2.